COMPASS Pathways (CMPS) Return on Capital Employed (2022 - 2026)
COMPASS Pathways (CMPS) reported Return on Capital Employed of 79.32% for Q1 2026, up 73.0% year-over-year from 45.85% in Q1 2025, and down 106.56% quarter-over-quarter from 1208.32% in Q4 2025.
COMPASS Pathways (CMPS) Return on Capital Employed (2022 - 2026) Analysis & Trends
COMPASS Pathways (CMPS) has 5 years of Return on Capital Employed data on file, last reported at 79.32% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 79.32%, up 73.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 79.32% (up 73.0% YoY), and the FY2025 annual result was 500.28%, up 58481.0% from the prior year.
- Return on Capital Employed fell to 79.32% in Q1 2026 per CMPS's latest filing, from 1208.32% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 1208.32% in Q4 2025 and troughed at 235.34% in Q3 2025.
- A 5-year average of 2.72% and a median of 56.81% in 2024 frame the typical range for Return on Capital Employed.
- On a YoY basis, Return on Capital Employed climbed as much as 129902 bps in 2025 and fell as far as 16429 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 56.53% in 2022, then advanced by 10 bps to 51.11% in 2023, then tumbled by 77 bps to 90.7% in 2024, then jumped by 1432 bps to 1208.32% in 2025, then tumbled by 107 bps to 79.32% in 2026.
- Business Quant data shows CMPS's Return on Capital Employed at 79.32% in Q1 2026, 1208.32% in Q4 2025, and 235.34% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -18.08% |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 15.90% |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 14.27% |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | -2.33% |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 9.57% |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 16.52% |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 12.19% |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 26.99% |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 8.38% |
| 10 | COMPASS Pathways | 1.38 Bn | 1.38 Bn | - | -79.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.32% |
| Dec 31, 2025 | 1,208.32% |
| Sep 30, 2025 | -235.34% |
| Jun 30, 2025 | -68.67% |
| Mar 31, 2025 | -80.05% |
| Dec 31, 2024 | -90.70% |
| Sep 30, 2024 | -71.05% |
| Jun 30, 2024 | -56.81% |
| Mar 31, 2024 | -52.62% |
| Dec 31, 2023 | -51.11% |
| Sep 30, 2023 | -54.67% |
| Jun 30, 2023 | -68.33% |
| Mar 31, 2023 | -67.09% |
| Dec 31, 2022 | -56.53% |
| Sep 30, 2022 | -52.73% |
| Jun 30, 2022 | -42.44% |
| Mar 31, 2022 | -34.58% |